Is EINECS 222-134-0 Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use EINECS 222-134-0? Is EINECS 222-134-0 safe for nursing mother and child? Does EINECS 222-134-0 extracts into breast milk? Does EINECS 222-134-0 has any long term or short term side effects on infants? Can EINECS 222-134-0 influence milk supply or can EINECS 222-134-0 decrease milk supply in lactating mothers?

On last update relevant published data concerning breastfeeding were not found. Pharmacokinetic data suggest that excretion into breast milk would be significant. However, it is considered safe for treatment of parasite infections like Amebiasis in children, with a dosage for children weighing over 5 kg that has been established by the manufacturer. It is a medication included in a same group and similar properties of Metronidazole.

No information is available on the clinical use of EINECS 222-134-0 during breastfeeding and no studies have evaluated adverse effects of EINECS 222-134-0 on the infant during breastfeeding, but presumably they are similar to those of the closely related drug, metronidazole, such as increased risk of oral and rectal infections. As with metronidazole, concern has been raised about exposure of healthy infants to EINECS 222-134-0 via breastmilk, because of possible mutagenicity and carcinogenicity. Based on the EINECS 222-134-0's elimination half-life of approximately 17 hours, the manufacturer recommends avoidance of breastfeeding for 96 after a single dose. Other drugs are available for bacterial vaginosis, and can be given vaginally, which should result in lower amounts in breastmilk.